28 May 2020 2 Min Read
GSK aiming at 1-billion doses of Covid-19 vaccine boosters
Adjuvants create stronger and longer-lasting immunity from vaccines, as at least 10 coronavirus trials move to human testing
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In